Usan Pharmaceuticals Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Usan Pharmaceuticals Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $280.5K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Usan Pharmaceuticals Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $280.5K Trade | TransData Nexus

Usan Pharmaceuticals Private Limited

Indian Pharmaceutical Exporter · Antimalarial & Antiparasitic Specialist · $280.5K Total Trade · DGFT Verified

Usan Pharmaceuticals Private Limited is an Indian pharmaceutical exporter with a total trade value of $280.5K across 2 products in 2 therapeutic categories. Based on 8 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Quinine ($200.0K), Indomethacin ($80.5K), .

Usan Pharmaceuticals Private Limited — Export Portfolio & Destination Treemap

Usan Pharmaceuticals Private Limited pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Usan Pharmaceuticals Private Limited? — Company Overview & Market Position

Usan Pharmaceuticals Private Limited, established on August 13, 1974, is a privately held pharmaceutical company headquartered in Mumbai, Maharashtra, India. The company is registered under the Corporate Identification Number (CIN) U24239MH1974PTC017730. With an authorized capital of ₹500,000 and a paid-up capital of ₹100,000, Usan Pharmaceuticals has been a significant player in the Indian pharmaceutical industry for over five decades.

The company specializes in the manufacturing and export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Their product portfolio encompasses a range of therapeutic categories, with a notable focus on antimalarial and antiparasitic agents, as well as analgesics and antipyretics. This strategic product diversification has enabled Usan Pharmaceuticals to cater to a broad spectrum of healthcare needs both domestically and internationally.

What Does Usan Pharmaceuticals Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Quinine$200.0K 2

Product Portfolio — Top 2 by Export Value

Usan Pharmaceuticals Private Limited exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Quinine	Antimalarial & Antiparasitic	$200.0K	4	1.0%	13
2	Indomethacin	Analgesics & Antipyretics	$80.5K	4	0.9%	13

Usan Pharmaceuticals Private Limited exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $280.5K. The top category is Antimalarial & Antiparasitic (71.3% of portfolio), followed by Analgesics & Antipyretics (28.7%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Usan Pharmaceuticals Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Usan Pharmaceuticals operates state-of-the-art manufacturing facilities in Mumbai, Maharashtra. These plants are equipped with modern machinery and adhere to stringent quality control measures to ensure the production of high-quality pharmaceutical formulations. The facilities are designed to handle the manufacturing of various dosage forms, including tablets, capsules, syrups, and injectables, catering to both domestic and international markets.

3Key Leadership

The leadership team at Usan Pharmaceuticals is spearheaded by Managing Director Vimal Jaswa, who has been at the helm since April 26, 2001. Under his guidance, the company has experienced significant growth and expansion in its operations. Julie Vimal Jaswa serves as a Director, contributing to the strategic direction and governance of the company. Their combined leadership has been instrumental in steering Usan Pharmaceuticals towards its current position in the pharmaceutical industry.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Usan Pharmaceuticals Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Usan Pharmaceuticals has made strategic inroads into several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has undertaken the necessary regulatory filings and approvals to ensure compliance with the stringent standards of these markets. This includes obtaining certifications and approvals from relevant regulatory bodies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other national health authorities. By meeting these regulatory requirements, Usan Pharmaceuticals has successfully positioned its products in these markets, demonstrating its commitment to quality and safety.

2Emerging Markets

In addition to established markets, Usan Pharmaceuticals has been actively exploring opportunities in emerging markets across Africa, Latin America, and Southeast Asia. The company has pursued World Health Organization (WHO) prequalification for its products, which is a critical step in gaining access to these regions. Achieving WHO prequalification enables Usan Pharmaceuticals to supply its products to international organizations and governments, thereby expanding its global footprint and contributing to global health initiatives.

3Geographic Strategy

Usan Pharmaceuticals Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Usan Pharmaceuticals has registered its manufacturing facilities with the U.S. Food and Drug Administration (FDA), ensuring compliance with U.S. regulatory standards. The company has also filed Abbreviated New Drug Applications (ANDAs) for its generic pharmaceutical products, facilitating market entry in the U.S. Additionally, Usan Pharmaceuticals has submitted Drug Master Files (DMFs) to the FDA, providing detailed information about the manufacturing processes and quality control measures of its products. The company has maintained a positive inspection history, reflecting its commitment to adhering to FDA guidelines and ensuring product quality.

2WHO & EU GMP

Usan Pharmaceuticals has achieved World Health Organization (WHO) prequalification for several of its products, demonstrating compliance with international quality standards. This certification is essential for supplying products to international organizations and governments. The company has also obtained European Union Good Manufacturing Practice (EU GMP) certificates, ensuring that its manufacturing processes meet the stringent requirements set by the European Medicines Agency (EMA). These certifications underscore Usan Pharmaceuticals' dedication to maintaining high-quality standards in its manufacturing operations.

Usan Pharmaceuticals Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

In the pharmaceutical industry, Usan Pharmaceuticals faces competition from both domestic and international companies operating in similar therapeutic categories. Key competitors include established Indian pharmaceutical firms with a global presence, as well as multinational corporations. While specific market share data is not publicly available, Usan Pharmaceuticals' focus on high-quality formulations and adherence to international standards positions it competitively in the market. The company's strategic emphasis on regulatory compliance and product diversification further enhances its competitive edge.

2Key Differentiators

Usan Pharmaceuticals distinguishes itself through its commitment to quality, as evidenced by its adherence to WHO and EU GMP standards. The company's diversified product portfolio, encompassing antimalarial and antiparasitic agents, as well as analgesics and antipyretics, allows it to cater to a wide range of therapeutic needs. Additionally, Usan Pharmaceuticals' proactive approach to obtaining regulatory approvals and certifications from global health authorities underscores its dedication to maintaining high standards and expanding its international market presence.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Usan Pharmaceuticals Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Usan Pharmaceuticals has demonstrated a consistent track record in manufacturing and exporting pharmaceutical formulations. The company's export volume and consistency are supported by its adherence to international quality standards and regulatory requirements. Reliability indicators include its positive inspection history with regulatory authorities and the absence of adverse regulatory actions. These factors collectively suggest that Usan Pharmaceuticals is a dependable supplier in the pharmaceutical sector.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Facility Registration: Confirm that the manufacturing facility is registered with the U.S. Food and Drug Administration.

WHO-GMP Certification: Ensure that the company holds World Health Organization Good Manufacturing Practice certification.

Frequently Asked Questions — Usan Pharmaceuticals Private Limited

How many pharmaceutical products does Usan Pharmaceuticals Private Limited export from India?

Usan Pharmaceuticals Private Limited exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Quinine ($200.0K), Indomethacin ($80.5K). Total export value is $280.5K.

What is Usan Pharmaceuticals Private Limited's total pharmaceutical export value?

Usan Pharmaceuticals Private Limited's total pharmaceutical export value is $280.5K, based on 8 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Usan Pharmaceuticals Private Limited cover?

Usan Pharmaceuticals Private Limited exports across 2 therapeutic categories. The largest are Antimalarial & Antiparasitic (71.3%, 1 products), Analgesics & Antipyretics (28.7%, 1 products).

Get Full Usan Pharmaceuticals Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.